Grants and Contributions:
Title:
Pre-clinical R and D of a novel non-opioid drug for the treatment of chronic pain
Agreement Number:
1024974
Agreement Value:
$75,000.00
Agreement Date:
Nov 1, 2024 - Mar 31, 2026
Description:
There is an urgent need to identify new therapeutic approaches for pain. The company has discovered a non-opioid based regulatory mechanism that provides potent pain relief. The company has validated its’ proprietary compounds on this new pain therapy target and the current project will concentrate on the chemical synthesis and biological validation studies to identify and develop back-up compounds as a risk mitigation strategy for the lead compounds currently in development.
Organization:
National Research Council Canada
Expected Results:
The expected results and outcomes of NRC Industrial Research Assistance Program is focused on growing small and medium-sized enterprises (SMEs) through innovation and wealth creation for Canada.
Location:
Calgary, Alberta, CA T2L 1Y8
Reference Number:
172-2024-2025-Q3-1024974
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
726311673
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 28 days.
Amendment Date
Feb 23, 2026
Recipient's Operating Name:
Zymedyne Therapeutics Inc
Recipient's Legal Name:
Zymedyne Therapeutics Inc
Federal Riding Name:
Calgary Confederation
Federal Riding Number:
48005
Program:
Industrial Research Assistance Program
Program Purpose:
The purpose of Industrial Research Assistance Program Contributions to Firms is to provide support that assists small and medium-sized enterprises (SMEs) to advance their innovation knowledge and ability to innovate, grow through innovation and stimulate wealth creation for Canada.
Coverage:
Industrial Research Assistance Program projects stimulate wealth creation for Canada through technological innovation and strengthen Canadian innovation ecosystem by creating new industrial capacity.
NAICS Code:
32541
Amendments: